Children's Automated Respiration Monitor (ChARM) for Child Pneumonia Diagnosis by Community Health Workers in Mali

Sponsor
Diego Bassani (Other)
Overall Status
Completed
CT.gov ID
NCT03457519
Collaborator
Canadian Red Cross (Other)
141
2
3
10.6
70.5
6.7

Study Details

Study Description

Brief Summary

The primary objective of this study is to estimate the impact of a self-monitoring tool (ChARM), used as a teaching/monitoring device, on the CHWs respiratory rate counting accuracy when assessing children under the age of 5 years with suspected pneumonia symptoms.

Condition or Disease Intervention/Treatment Phase
  • Device: Children's Automated Respiration Monitor (ChARM)
N/A

Detailed Description

Methodology:

The study is designed as a community based, cluster randomized, pragmatic, intervention trial. It will be conducted within the existing 2016-2020 project structure. Specifically, the intervention will evaluate the potential of the ChARM device to improve CHWs competency in counting respiratory rate and diagnose pneumonia more accurately in children under 5 years presenting with symptoms in remote areas.

Intervention Group A - Community Health Workers (CHWs) (Basic training in CHW curriculum, ChARM training and 8-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018.

Intervention Group B - Community Health Workers (Basic training in CHW curriculum, ChARM training and 4-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): 8 months,March- November 2018.

Control Group C - Community Health Workers (Basic training in CHW curriculum, direct observation and CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018.

CHW and Field Monitor In-depth interviews - November 2018

Data analysis and report writing - December 2018-January 2019

Study Design

Study Type:
Interventional
Actual Enrollment :
141 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Intervention Group A - Community Health Workers (CHWs) (Basic training in CHW curriculum, ChARM training and 8-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018. Intervention Group B - Community Health Workers (Basic training in CHW curriculum, ChARM training and 4-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): March- November 2018. Control Group C - Community Health Workers (Basic training in CHW curriculum, direct observation and CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018.Intervention Group A - Community Health Workers (CHWs) (Basic training in CHW curriculum, ChARM training and 8-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018. Intervention Group B - Community Health Workers (Basic training in CHW curriculum, ChARM training and 4-month application of the ChARM device, self-monitoring, direct observation and review of CHW routine monthly reports and drug supply sheets): March- November 2018. Control Group C - Community Health Workers (Basic training in CHW curriculum, direct observation and CHW routine monthly reports and drug supply sheets): 8 months, March- November 2018.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Children's Automated Respiration Monitor (ChARM) for Child Pneumonia Diagnosis by Community Health Workers in Mali: Innovating ChARM's Role in Supervision, Training and Diagnosis, a Cluster Randomized Control Trial
Actual Study Start Date :
Mar 5, 2018
Actual Primary Completion Date :
Jan 21, 2019
Actual Study Completion Date :
Jan 21, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention Group A

CHWs trained in ChARM and using ChARM as a self-monitoring tool for 8 months while counting respiratory rate of children under 5 visually using a timer. Intervention: The Children's Respiration Monitor (also known as ChARM) device is routinely used to diagnose Pneumonia cases but in this study it will be used as a self-monitoring and teaching aide for strengthening CHWs skills.

Device: Children's Automated Respiration Monitor (ChARM)
The Philips CHARM (children's automatic respiratory monitor) is specifically designed to detect pneumonia in low resource areas. The lightweight measuring device sits on a child's or infant's chest, secured by a strap and measures respiration rate (fast breathing) through an ingenious algorithm. In this study ChARM will be used as a self monitoring and teaching aide by the CHWS.

Active Comparator: Intervention Group B

CHWs trained in ChARM and using ChARM as a self-monitoring tool for 4 months while counting respiratory rate of children under 5 visually using a time; then discontinue using ChARM and continue to monitor the respiratory rate visually using a timer only for the remaining 4 months. Intervention: The Children's Respiration Monitor (also known as ChARM) device is routinely used to diagnose Pneumonia cases but in this study it will be used as a self-monitoring and teaching aide for strengthening CHWs skills.

Device: Children's Automated Respiration Monitor (ChARM)
The Philips CHARM (children's automatic respiratory monitor) is specifically designed to detect pneumonia in low resource areas. The lightweight measuring device sits on a child's or infant's chest, secured by a strap and measures respiration rate (fast breathing) through an ingenious algorithm. In this study ChARM will be used as a self monitoring and teaching aide by the CHWS.

No Intervention: Control Group C

CHWs who did not receive the ChARM training and will be monitoring the respiratory rate of children under 5 visually using a timer only, as per the MoH traditional training.

Outcome Measures

Primary Outcome Measures

  1. Acute Respiratory Illness (ARI) Case fatality rate [8 months]

    Acute Respiratory Illness (ARI) Case fatality rate defined as number of deaths from respiratory infections among children diagnosed with respiratory infections

Secondary Outcome Measures

  1. Respiratory rate counting accuracy [8 months]

    Respiratory rate is defined as the number of breaths taken per minute

  2. Proportion of pneumonia cases detected and treated by CHWs [8 months]

    Proportion of pneumonia cases detected by the CHWs that are treated by CHWs

  3. Proportion of suspected severe pneumonia cases referred by CHWs to the CSCom [8 months]

    Proportion of all suspected severe pneumonia cases identified by the CHWs (based on presence of fever and increased respiratory rates for age) referred by CHWs to the CSCom

  4. Proportion of suspected pneumonia cases in the community who sought care from a CHW [8 months]

    Proportion of self-referenced pneumonia cases in the community (via household survey) who report seeking care from a CHW

  5. Accuracy in drug management and procurement requests [8 months]

    Percent of CHW with no stock-outs in the last 4 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • • Be currently providing iCCM services on a full-time basis to the populations they are serving.

  • Have completed the Malian Ministry of Health basic community health care worker training provided as part of the 2016-2020 Strengthening Maternal, Newborn and Child Health project.

  • Are using a device (a respiratory timer) as part of their basic MoH training package, or have a cell phone to use to count the respiratory rates of children under five with suspected symptoms of pneumonia.

  • Be willing to participate in a trial to study the impact of using ChARM as a self-monitoring tool to improve the capacity to detect pneumonia.

Exclusion Criteria:
  • • CHWs in conflict ridden geographical areas within the district or not, providing consistent services on a full-time basis to the populations they are serving.

  • CHWs not willing to participate in the trial.

  • CHWs who do not have a device (watch, respiratory timer or cell phone) to support measurement of respiratory rates and who are not routinely counting respiratory rate to diagnose suspected pneumonia.

  • CHWs who did not complete the MoH basic training for CHWs provided through the 2016-2020 Strengthening Maternal, Newborn and Child Health program

Contacts and Locations

Locations

Site City State Country Postal Code
1 iCCM sites Banamba Koulikoro Mali
2 iCCM Sites Koulikoro Mali

Sponsors and Collaborators

  • Diego Bassani
  • Canadian Red Cross

Investigators

  • Principal Investigator: Diego G Bassani, PhD, University of Toronto

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Diego Bassani, Director, International Program Evaluation Unit (IPE), Center for Global Child Health, The Hospital for Sick Children
ClinicalTrials.gov Identifier:
NCT03457519
Other Study ID Numbers:
  • R-ST-POC-1707-07682
First Posted:
Mar 7, 2018
Last Update Posted:
Jun 25, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Diego Bassani, Director, International Program Evaluation Unit (IPE), Center for Global Child Health, The Hospital for Sick Children
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 25, 2019